Kinsale Capital Partners
Kinsale Capital Partners, LLC is a private equity firm based in Chicago, Illinois, founded in 2010. The firm specializes in management-led leveraged buyouts and offers targeted acquisition services, distressed investment advice, and financing solutions, including bridge financing and corporate restructuring. Kinsale focuses on small to lower middle-market companies, particularly in sectors such as business and industrial services, consumer services, niche manufacturing, value-added distribution, media and publishing, information technology, telecommunications, and healthcare. The firm typically seeks investment opportunities in companies with revenues between $10 million and $100 million, primarily in the United States, Eastern China, and select regions in Western Europe and South America. Kinsale Capital Partners invests its own capital along with co-investments from a network of co-investors, and it often pursues add-on acquisitions to enhance the value of its core investments.
GeneriCo, LLC is a pharmaceutical company that specializes in the development and marketing of generic medications, particularly in therapeutic areas such as cardiovascular health, pain management, central nervous system disorders, oncology, and age-related conditions. Founded in 2013 and headquartered in Saint Louis, Missouri, GeneriCo also operates offices in Bengaluru, India; Italy; and South Korea. The company focuses on niche generic pharmaceuticals that larger competitors often overlook, particularly those that involve complex formulations and advanced drug delivery technologies. By targeting these neglected areas, GeneriCo aims to fill gaps in the market and provide valuable treatments for healthcare professionals, ultimately enhancing the quality of life for patients worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.